TNFSF10 and renal carcinoma: The combinatorial treatment with TRAIL and PIs can significantly increase the induction of apoptotic cell death in some human cancers, including multiple myeloma, renal carcinoma and NSCLC cells, which were not sensitive to either TRAIL alone or PI alone treatment [23,27].